Your search produced the following search result(s) for these filters:
Category: Categories: (Drug Development)

Exhibitor List Index

 

COMPANY NAME BOOTH# Enhanced
AbbVie 6097 UpgradedConquer Cancer®, the ASCO Foundation DonorFacebookTwitterLinkedIn
Accell Clinical Research 17098
ADC Therapeutics 25155 ASCO FirstTwitterLinkedIn
Alkermes, Inc. 20153 ASCO FirstTwitterLinkedIn
Allucent 22121 Upgraded
Arcus Biosciences 26117 ASCO FirstTwitterLinkedIn
Astex Pharmaceuticals, Inc. 23135 Upgraded
AVEO Oncology, an LG Chem company 20147 FacebookTwitterLinkedIn
AVM Biotechnology 28155 FacebookTwitterLinkedIn
BeiGene 21153 UpgradedConquer Cancer®, the ASCO Foundation DonorConquer Cancer Council MemberTwitterLinkedIn
BeiGene 18158 UpgradedConquer Cancer®, the ASCO Foundation DonorConquer Cancer Council Member
Biognosys AG 26096 ASCO FirstTwitterLinkedIn
Biolexis Therapeutics, Inc. 28081 ASCO FirstLinkedIn
Caidya 20112 LinkedIn
Cardinal Health 18123 UpgradedFacebookTwitterLinkedIn
Certara 22128 FacebookLinkedIn
Cleveland Clinic Taussig Cancer Institute 3026
Cmed Inc. 22088 LinkedIn
CMIC Group / CMIC Shiftzero 25081 TwitterLinkedIn
CRISPR Therapeutics 2110 ASCO FirstTwitterLinkedIn
Curis, Inc. 26100 UpgradedTwitterLinkedIn
Daiichi Sankyo 13081 UpgradedConquer Cancer®, the ASCO Foundation DonorConquer Cancer Council MemberTwitterLinkedIn
DAVA Oncology 2062
DAVA Oncology 3046
Early Access Care 15025 UpgradedLinkedIn
eClinical Solutions IH09 UpgradedASCO FirstTwitterLinkedIn
Elevar Therapeutics 28089 ASCO FirstLinkedIn
Exelixis, Inc. 18063 Conquer Cancer®, the ASCO Foundation DonorConquer Cancer Council Member
Genentech 10097 UpgradedConquer Cancer®, the ASCO Foundation DonorConquer Cancer Council MemberFacebookTwitterLinkedIn
GSK 10119 UpgradedConquer Cancer®, the ASCO Foundation DonorConquer Cancer Council MemberFacebookTwitterLinkedIn
Helsinn Healthcare 6025 UpgradedConquer Cancer®, the ASCO Foundation DonorConquer Cancer Council MemberTwitterLinkedIn
Hoosier Cancer Research Network 6160 FacebookTwitterLinkedIn
HUTCHMED 22123 UpgradedASCO FirstLinkedIn
iBio, Inc. 28087 UpgradedASCO FirstFacebookLinkedIn
Indivumed GmbH 25107 TwitterLinkedIn
Interpace Pharma Solutions 17096 FacebookTwitterLinkedIn
Ipsen 16024 TwitterLinkedIn
IQVIA 17081 UpgradedFacebookTwitterLinkedIn
Karyopharm Therapeutics Inc. 18152 UpgradedTwitterLinkedIn
KIYATEC IH01 UpgradedASCO FirstTwitterLinkedIn
KoNECT (Korea National Enterprise for Clinical Trials) 26149
Labcorp Oncology 24085 FacebookTwitterLinkedIn
Legend Biotech USA 2113 UpgradedASCO FirstTwitterLinkedIn
Linical 6146 FacebookTwitterLinkedIn
Luzsana Biotechnology 27155 UpgradedTwitterLinkedIn
Medidata, a Dassault Systèmes company 3037 FacebookTwitterLinkedIn
Medpace Inc. 4157 FacebookLinkedIn
Merck & Co., Inc. 24155 Conquer Cancer Council Member
Mirati Therapeutics 2097 ASCO FirstFacebookTwitterLinkedIn
MorphoSys AG 26125 TwitterLinkedIn
NanoMosaic 2064 ASCO FirstLinkedIn
National Organization for Rare Disorders (NORD) 3005 FacebookTwitterLinkedIn
ORGANOIDSCIENCES LTD 28086 ASCO FirstFacebookLinkedIn
Parexel 5099 FacebookTwitterLinkedIn
PathAI IH02 Upgraded
Precision for Medicine 22107 UpgradedLinkedIn
Radiomics 3136 ASCO FirstTwitterLinkedIn
Rain Oncology Inc. 5116 ASCO FirstTwitterLinkedIn
Realm IDx, Inc. 3117 UpgradedFacebookTwitterLinkedIn
Regeneron Pharmaceuticals 27149 Conquer Cancer Council MemberTwitterLinkedIn
Sanyou Bio 23118 FacebookLinkedIn
Sarah Cannon Research Institute 5036 Conquer Cancer®, the ASCO Foundation DonorFacebookTwitterLinkedIn
Seagen Inc. 18073 UpgradedConquer Cancer®, the ASCO Foundation Donor
SOTIO Biotech 7159 Upgraded
Spectrum Pharmaceuticals, Inc. 2051
Strata Oncology 23141
Syapse 18143 FacebookTwitterLinkedIn
Syneos Health 5135 FacebookTwitterLinkedIn
Tempus 5063 UpgradedTwitterLinkedIn
Theradex 21113
Theralink Technologies Inc. 14110
Tigermed 28145 ASCO FirstLinkedIn
Translational Drug Development (TD2) 2126 ASCO First
VERU Inc. 23125 UpgradedASCO FirstFacebookTwitterLinkedIn
Worldwide Clinical Trials 2056 UpgradedFacebookLinkedIn
WuXi Clinical 28151 TwitterLinkedIn
Xcovery Holdings, Inc. 5127